Scholarlink

Background <p>Colorectal cancer (CRC) is the third most common cause of cancer deaths worldwide, and has a poor prognosis in advanced stages. Whereas there are limited effective biomarkers of CRC. Herein, we aimed to explore the potential prognostic value of immune and ferroptosis-related genes (IFRGs).</p> Methods <p>CRC-related data were extracted from the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Kaplan-Meier, receiver operating characteristic (ROC), and multivariate Cox regression analyses were used to test the prognostic value of IFRGs. The immune cell infiltration and immunotherapy response predictive analyses were also conducted. The level of cysteine dioxygenase type 1 (CDO1) mRNA and protein expression in CRC and normal tissues was examined using quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blotting analysis, respectively.</p> Results <p>Thirty-eight IFRGs were obtained through differentially expressed gene analysis and cross-analysis. Of them, CDO1 mRNA and protein expression levels were significantly reduced in CRC tissues compared to normal tissues. CDO1 remained as an independent prognostic biomarker after multivariate Cox regression. Additionally, CDO1 hypermethylation was associated with poorer prognosis of CRC patients. CRC patients with differential CDO1 expression or methylation status both showed significantly distinct immune cell infiltration and immunotherapy responses.</p> Conclusions <p>Our study revealed CDO1 as an IFRG with a prognostic role in CRC. It may provide a rationale for developing novel treatment strategies, such as demethylating agents or combination immunotherapy protocols, for CRC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Identification of immune and ferroptosis-related gene cysteine dioxygenase type 1 (CDO1) as a prognostic biomarker in colorectal cancer, relating to immunotherapy response distinction

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月16日

查看全文
  • Shuo Chen,
  • Mingyue Xu,
  • Weijun Su,
  • Kai Wang,
  • Siqi Zhang,
  • Xipeng Zhang,
  • Lin Zhang

摘要

Background

Colorectal cancer (CRC) is the third most common cause of cancer deaths worldwide, and has a poor prognosis in advanced stages. Whereas there are limited effective biomarkers of CRC. Herein, we aimed to explore the potential prognostic value of immune and ferroptosis-related genes (IFRGs).

Methods

CRC-related data were extracted from the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Kaplan-Meier, receiver operating characteristic (ROC), and multivariate Cox regression analyses were used to test the prognostic value of IFRGs. The immune cell infiltration and immunotherapy response predictive analyses were also conducted. The level of cysteine dioxygenase type 1 (CDO1) mRNA and protein expression in CRC and normal tissues was examined using quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blotting analysis, respectively.

Results

Thirty-eight IFRGs were obtained through differentially expressed gene analysis and cross-analysis. Of them, CDO1 mRNA and protein expression levels were significantly reduced in CRC tissues compared to normal tissues. CDO1 remained as an independent prognostic biomarker after multivariate Cox regression. Additionally, CDO1 hypermethylation was associated with poorer prognosis of CRC patients. CRC patients with differential CDO1 expression or methylation status both showed significantly distinct immune cell infiltration and immunotherapy responses.

Conclusions

Our study revealed CDO1 as an IFRG with a prognostic role in CRC. It may provide a rationale for developing novel treatment strategies, such as demethylating agents or combination immunotherapy protocols, for CRC.